Huakang Biomedical Holdings Company Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CNY 6.31 million compared to CNY 6.95 million a year ago. Net loss was CNY 1.04 million compared to net income of CNY 0.386 million a year ago. Basic loss per share from continuing operations was CNY 0.0025 compared to basic earnings per share from continuing operations of CNY 0.0009 a year ago.
For the nine months, sales was CNY 17.77 million compared to CNY 18.75 million a year ago. Net loss was CNY 2.5 million compared to CNY 0.555 million a year ago. Basic loss per share from continuing operations was CNY 0.006 compared to CNY 0.0013 a year ago.